ARCHIVES

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

This article is from The Cancer Letter archive.

Vol. 27 No. 18 | May 4, 2001

Download PDF Visit The Full Archive

Related Articles

Pain Relievers Protect Against Breast Cancer

April 25, 2003

New: Special Reports on the Dialogue and NCI’s 2015 goal posted at cancerletter.com.

August 8, 2003

Amgen Pays $24.9 Million To Settle Kickback Charges

April 19, 2013

CTEP Deploys Website To Track Trial Activation

December 10, 2010

ACS Stirs Discord By Placing Its Own Logo On A Coalition’s Petition, Then Reconsiders

February 7, 1997

Bush Proposes $27.9 Billion for NIH, Plus $1.4B Reprogram From FY03

February 7, 2003